Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1450
+0.0050 (3.57%)
Feb 9, 2026, 9:04 AM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 19.6 million as of February 9, 2026. Its market cap has decreased by -41.30% in one year.
Market Cap
19.60M
Enterprise Value
25.26M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 19.60M, a decrease of -69.26%. That is a compound annual growth rate of -15.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 19.60M | 11.04% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thiogenesis Therapeutics | 32.40M |
| Microbix Biosystems | 31.17M |
| Resverlogix | 30.21M |
| Telescope Innovations | 29.09M |
| Devonian Health Group | 27.66M |
| Quantum BioPharma | 21.86M |
| Hemostemix | 17.57M |
| Britannia Life Sciences | 16.23M |